Skip to main content
. Author manuscript; available in PMC: 2021 Nov 22.
Published in final edited form as: Genet Med. 2019 Jun 4;21(11):2431–2438. doi: 10.1038/s41436-019-0549-3

Table 1.

Comparison of CPADs and CPGs

Key feature CPADs CPGs

State of field and testing technology Early in assessment of the field and testing technology Later in assessment of the field and testing technology
State of the evidence Insufficient evidence to evaluate benefits and harms of testing Sufficient evidence to evaluate benefits and harms of testing
Product(s) (1) Advice for clinicians based largely on expert judgment about the potential benefits and harms of testing, the uncertainties in current evidence, and the trade-offs for different approaches
(2) Recommendations for research to improve clinical test use
Recommendations for clinical practice based on evaluation of the evidence, with strength of recommendations determined by quality of evidence
Updating Annual review of relevant evidence with revision of CPAD or decision to proceed to CPG Appropriate plan for updating, as determined after CPG development

CPAD clinical practice advisory document, CPG clinical practice guideline.